Verve Therapeutics raised €56M in a Series A round in Jun 2020. The company is based in Cambridge, United States. Investors in the round: GV. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €56M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
